The use of laparoscopic liver biopsies in pediatric patients with hepatic dysfunction following allogeneic hematopoietic stem cell transplantation

S. W. Choi, S. Islam, J. K. Greenson, J. Levine, R. Hutchinson, G. Yanik, D. H. Teitelbaum, J. L M Ferrara, Kenneth R Cooke

Research output: Contribution to journalArticle

Abstract

Hepatic dysfunction following hematopoietic stem cell transplantation (HSCT) is common, but making the correct diagnosis can be challenging. Liver biopsies can serve as an important diagnostic tool when the etiology cannot be clearly determined by laboratory data, physical examination, and imaging studies. We reviewed 12 consecutive pediatric patients (seven males, five females, age 9-23 years) who received allogeneic HSCT and underwent a laparoscopic-guided liver biopsy for hepatic dysfunction of unknown etiology from 1998 to 2005. Biopsies were performed using a single-port technique with a 16 or 18 gauge, spring-loaded biopsy gun. The time from HSCT to biopsy ranged from 31 days to 821 days (median 92 days). No intra- or postoperative complications were observed. The initial clinical diagnosis was confirmed in seven patients, whereas the initial working diagnosis was inaccurate in the remaining five patients. Our results suggest that laparoscopic-guided liver biopsy is an informative and safe procedure in pediatric HSCT recipients; this approach helped delineate the true cause of hepatic dysfunction and changed our therapeutic approach in approximately 40% of the patients reviewed. While the safety record at our institution appears promising, a larger multi-institutional study would be necessary to more accurately describe the overall efficacy of this procedure in pediatric HSCT patients.

Original languageEnglish (US)
Pages (from-to)891-896
Number of pages6
JournalBone Marrow Transplantation
Volume36
Issue number10
DOIs
StatePublished - Nov 2005
Externally publishedYes

Fingerprint

Hematopoietic Stem Cell Transplantation
Pediatrics
Biopsy
Liver
Intraoperative Complications
Firearms
Physical Examination
Safety

Keywords

  • Allogenetic HSCT
  • GVHD
  • Hepatic dysfunction
  • Laparoscopic liver biopsy
  • Pediatric patients
  • VOD

ASJC Scopus subject areas

  • Hematology
  • Transplantation

Cite this

The use of laparoscopic liver biopsies in pediatric patients with hepatic dysfunction following allogeneic hematopoietic stem cell transplantation. / Choi, S. W.; Islam, S.; Greenson, J. K.; Levine, J.; Hutchinson, R.; Yanik, G.; Teitelbaum, D. H.; Ferrara, J. L M; Cooke, Kenneth R.

In: Bone Marrow Transplantation, Vol. 36, No. 10, 11.2005, p. 891-896.

Research output: Contribution to journalArticle

Choi, S. W. ; Islam, S. ; Greenson, J. K. ; Levine, J. ; Hutchinson, R. ; Yanik, G. ; Teitelbaum, D. H. ; Ferrara, J. L M ; Cooke, Kenneth R. / The use of laparoscopic liver biopsies in pediatric patients with hepatic dysfunction following allogeneic hematopoietic stem cell transplantation. In: Bone Marrow Transplantation. 2005 ; Vol. 36, No. 10. pp. 891-896.
@article{e6c1e436a5014f7b9b2a3299d766468b,
title = "The use of laparoscopic liver biopsies in pediatric patients with hepatic dysfunction following allogeneic hematopoietic stem cell transplantation",
abstract = "Hepatic dysfunction following hematopoietic stem cell transplantation (HSCT) is common, but making the correct diagnosis can be challenging. Liver biopsies can serve as an important diagnostic tool when the etiology cannot be clearly determined by laboratory data, physical examination, and imaging studies. We reviewed 12 consecutive pediatric patients (seven males, five females, age 9-23 years) who received allogeneic HSCT and underwent a laparoscopic-guided liver biopsy for hepatic dysfunction of unknown etiology from 1998 to 2005. Biopsies were performed using a single-port technique with a 16 or 18 gauge, spring-loaded biopsy gun. The time from HSCT to biopsy ranged from 31 days to 821 days (median 92 days). No intra- or postoperative complications were observed. The initial clinical diagnosis was confirmed in seven patients, whereas the initial working diagnosis was inaccurate in the remaining five patients. Our results suggest that laparoscopic-guided liver biopsy is an informative and safe procedure in pediatric HSCT recipients; this approach helped delineate the true cause of hepatic dysfunction and changed our therapeutic approach in approximately 40{\%} of the patients reviewed. While the safety record at our institution appears promising, a larger multi-institutional study would be necessary to more accurately describe the overall efficacy of this procedure in pediatric HSCT patients.",
keywords = "Allogenetic HSCT, GVHD, Hepatic dysfunction, Laparoscopic liver biopsy, Pediatric patients, VOD",
author = "Choi, {S. W.} and S. Islam and Greenson, {J. K.} and J. Levine and R. Hutchinson and G. Yanik and Teitelbaum, {D. H.} and Ferrara, {J. L M} and Cooke, {Kenneth R}",
year = "2005",
month = "11",
doi = "10.1038/sj.bmt.1705158",
language = "English (US)",
volume = "36",
pages = "891--896",
journal = "Bone Marrow Transplantation",
issn = "0268-3369",
publisher = "Nature Publishing Group",
number = "10",

}

TY - JOUR

T1 - The use of laparoscopic liver biopsies in pediatric patients with hepatic dysfunction following allogeneic hematopoietic stem cell transplantation

AU - Choi, S. W.

AU - Islam, S.

AU - Greenson, J. K.

AU - Levine, J.

AU - Hutchinson, R.

AU - Yanik, G.

AU - Teitelbaum, D. H.

AU - Ferrara, J. L M

AU - Cooke, Kenneth R

PY - 2005/11

Y1 - 2005/11

N2 - Hepatic dysfunction following hematopoietic stem cell transplantation (HSCT) is common, but making the correct diagnosis can be challenging. Liver biopsies can serve as an important diagnostic tool when the etiology cannot be clearly determined by laboratory data, physical examination, and imaging studies. We reviewed 12 consecutive pediatric patients (seven males, five females, age 9-23 years) who received allogeneic HSCT and underwent a laparoscopic-guided liver biopsy for hepatic dysfunction of unknown etiology from 1998 to 2005. Biopsies were performed using a single-port technique with a 16 or 18 gauge, spring-loaded biopsy gun. The time from HSCT to biopsy ranged from 31 days to 821 days (median 92 days). No intra- or postoperative complications were observed. The initial clinical diagnosis was confirmed in seven patients, whereas the initial working diagnosis was inaccurate in the remaining five patients. Our results suggest that laparoscopic-guided liver biopsy is an informative and safe procedure in pediatric HSCT recipients; this approach helped delineate the true cause of hepatic dysfunction and changed our therapeutic approach in approximately 40% of the patients reviewed. While the safety record at our institution appears promising, a larger multi-institutional study would be necessary to more accurately describe the overall efficacy of this procedure in pediatric HSCT patients.

AB - Hepatic dysfunction following hematopoietic stem cell transplantation (HSCT) is common, but making the correct diagnosis can be challenging. Liver biopsies can serve as an important diagnostic tool when the etiology cannot be clearly determined by laboratory data, physical examination, and imaging studies. We reviewed 12 consecutive pediatric patients (seven males, five females, age 9-23 years) who received allogeneic HSCT and underwent a laparoscopic-guided liver biopsy for hepatic dysfunction of unknown etiology from 1998 to 2005. Biopsies were performed using a single-port technique with a 16 or 18 gauge, spring-loaded biopsy gun. The time from HSCT to biopsy ranged from 31 days to 821 days (median 92 days). No intra- or postoperative complications were observed. The initial clinical diagnosis was confirmed in seven patients, whereas the initial working diagnosis was inaccurate in the remaining five patients. Our results suggest that laparoscopic-guided liver biopsy is an informative and safe procedure in pediatric HSCT recipients; this approach helped delineate the true cause of hepatic dysfunction and changed our therapeutic approach in approximately 40% of the patients reviewed. While the safety record at our institution appears promising, a larger multi-institutional study would be necessary to more accurately describe the overall efficacy of this procedure in pediatric HSCT patients.

KW - Allogenetic HSCT

KW - GVHD

KW - Hepatic dysfunction

KW - Laparoscopic liver biopsy

KW - Pediatric patients

KW - VOD

UR - http://www.scopus.com/inward/record.url?scp=27844582310&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=27844582310&partnerID=8YFLogxK

U2 - 10.1038/sj.bmt.1705158

DO - 10.1038/sj.bmt.1705158

M3 - Article

C2 - 16184184

AN - SCOPUS:27844582310

VL - 36

SP - 891

EP - 896

JO - Bone Marrow Transplantation

JF - Bone Marrow Transplantation

SN - 0268-3369

IS - 10

ER -